Sebastian A. Meier-Ewert
Algemeen Directeur bij Prosalix GmbH
Oorsprong van het eerstegraads netwerk van Sebastian A. Meier-Ewert
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
GPC Biotech AG
GPC Biotech AG Miscellaneous Commercial ServicesCommercial Services GPC Biotech AG is a biotechnology company discovering and developing new anticancer drugs.It is headquartered in Martinsried/Munich (Germany). The Company's wholly owned U.S. subsidiary has research and development sites in Waltham, Massachusetts and Princeton, New Jersey
16
| Extinct | Miscellaneous Commercial Services | 16 |
GPC Biotech, Inc.
GPC Biotech, Inc. Drugstore ChainsRetail Trade GPC Biotech, Inc. discovers and develops anticancer drugs through discovery technologies and development approaches. It is a mechanism-based drug discovery and development company focused on treatments for cancer and fungal infections. The company is a wholly owned subsidiary of GPC Biotech AG. GPC Biotech was founded in 1992 and is located in Waltham, MA.
11
| Subsidiary | Drugstore Chains | 11 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Sebastian A. Meier-Ewert via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
BAXTER INTERNATIONAL INC. | Medical Specialties | General Counsel | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal | |
Oscient Pharmaceuticals Corp.
Oscient Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Oscient Pharmaceuticals Corp. is a biopharmaceutical company that sells and markets products to community-based primary care physicians through its primary care sales force in the United States. It markets two products namely, ANTARA fenofibrate capsules, a cardiovascular product and FACTIVE gemifloxacin mesylate tablets, a fluoroquinolone antibiotic. It also has late-stage antibiotic candidate, Ramoplanin for the treatment of clostridium difficile-associated disease. The company was founded on May 09, 1961 and is headquartered in Waltham, MA. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
TRI-CONTINENTAL CORPORATION | Investment Trusts/Mutual Funds | Director/Board Member | |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Medical Specialties | Director/Board Member | |
Genaissance Pharmaceuticals, Inc.
Genaissance Pharmaceuticals, Inc. BiotechnologyHealth Technology Genaissance Pharmaceuticals, Inc. develops and uses genetic information to diagnostic and therapeutic products. The company was founded by Kevin L. Rakin and Gualberto Ruano in 1992 and is headquartered in New Haven, CT. | Biotechnology | Chairman | |
TRANSGENE | Biotechnology | Chief Tech/Sci/R&D Officer Public Communications Contact | |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal | |
RADIUS HEALTH, INC. | Biotechnology | Director/Board Member General Counsel | |
Ulthera, Inc.
Ulthera, Inc. Medical SpecialtiesHealth Technology Ulthera, Inc. provides ultrasound therapy under the Ultherapy brand. It focuses on ultrasound imaging to to deliver its collagen-boosting treatment. The company was founded by Peter G. Barthe, Inder Raj S. Makin, Brain D. Oconner, Lana Slayton, and Michael H. Slayto n in April 2004 and is headquartered in Raleigh, NC. | Medical Specialties | Director/Board Member | |
AbCellera Boston, Inc.
AbCellera Boston, Inc. BiotechnologyHealth Technology AbCellera Boston, Inc. produces vaccines for plant, animal, and human diseases. It focuses on the discovery of novel therapeutics for autoimmune disease and pain. The company was founded by Theodore G. Clark in 2004 and is headquartered in Arlington, MA. | Biotechnology | Director/Board Member | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Graduate Degree Corporate Officer/Principal | |
Boston Children's Heart Foundation, Inc.
Boston Children's Heart Foundation, Inc. Medical/Nursing ServicesHealth Services Boston Children's Heart Foundation, Inc. is an organization that focuses on graduate medical education at Boston Children's Hospital. Additionally, they provide resources and information on kidney stones and how to transfer a patient to Boston Children's Hospital for treatment. The private company is based in Boston, MA. The company is committed to educating and preparing physicians for excellence in their field. The CEO of the company is Kevin B. Churchwell. | Medical/Nursing Services | Director/Board Member | |
George Washington University | College/University | Graduate Degree | |
SANTHERA PHARMACEUTICALS HOLDING AG | Pharmaceuticals: Major | Director/Board Member Chairman | |
Rutgers State University of New Jersey | College/University | Corporate Officer/Principal Doctorate Degree | |
Mount Ida College | College/University | Director/Board Member | |
Princeton University | College/University | Corporate Officer/Principal Undergraduate Degree | |
State University of New York at Buffalo | College/University | Masters Business Admin | |
University of Delaware | College/University | Undergraduate Degree | |
The Children's Hospital Corp.
The Children's Hospital Corp. Medical/Nursing ServicesHealth Services Children's Hospital Corp. engages in the provision of pediatric care services. It offers acupuncture, angioplasty, antibiotic allergy testing, audiogram, baclofen pump, biochemical genetic testing, blended diet, bone scan, brain scan, breast augmentation surgery, cardiac catheterization, cardiac MRI in children, chest reconstruction surgery, and CO2 laser treatment. The company was founded by Francis Henry Brown in 1869 and is headquartered in Boston, MA. | Medical/Nursing Services | Director/Board Member | |
INNATE PHARMA | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
The International Women's Forum
The International Women's Forum Miscellaneous Commercial ServicesCommercial Services Part of Leadership Foundations, The International Women's Forum is a women's forum membership organization. The company is based in Washington. The American company was founded in 1974 by Maureen A. Kindel, Elinor Guggenheimer. Stephanie Mathews O'Keefe has been the CEO of the company since 2016. The International Women's Forum was acquired by Leadership Foundations on January 01, 2021. | Miscellaneous Commercial Services | Director/Board Member | |
The European Molecular Biology Laboratory | College/University | Corporate Officer/Principal | |
EBS Universität für Wirtschaft und Recht gGmbH
EBS Universität für Wirtschaft und Recht gGmbH Other Consumer ServicesConsumer Services EBS Universität für Wirtschaft und Recht gGmbH functions as a college or university. Its services include academic, coaching@EBS, career services center, EBS languages center, accommodation database and EBS mediations services. The company is headquartered in Wiesbaden, Germany. | College/University | Doctorate Degree Doctorate Degree | |
The Children's Medical Center Corp.
The Children's Medical Center Corp. Hospital/Nursing ManagementHealth Services The Children's Medical Center Corp. operates as a non-profit hospital and research center. The company was founded in 1959 and is headquartered in Boston, MA. | Hospital/Nursing Management | Director/Board Member | |
International Relief & Development, Inc.
International Relief & Development, Inc. Services to the Health IndustryHealth Services International Relief & Development, Inc. provides cost effective relief and development programs. It offers democracy, governance and community development, economic growth, emergency response, health and hygiene, as well as rebuilding infrastructure. The company was founded by Dr. Arthur B. Keys Jr. in 1998 and is headquartered in Arlington, Arlington, VA. | Services to the Health Industry | Director/Board Member | |
Harvard Medical School | College/University | Corporate Officer/Principal Doctorate Degree | |
Merz Pharma GmbH & Co. KGaA
Merz Pharma GmbH & Co. KGaA Miscellaneous Commercial ServicesCommercial Services Merz Pharma GmbH & Co. KGaA is an innovative and international healthcare company with its own research and development department. It focuses on drugs for the treatment of illness in the fields of neurology and psychiatry. The company is bundling the activities of its subsidiaries Merz Pharmaceuticals, Merz Consumer Care, Merz Dental, and Merz Hygiene, with products ranging from prescription drugs and OTC products for health and wellness, materials for dentists and dental technicians to hygienic products for medical disinfection and cleaning. The units of Merz Group Services, the fith Merz subsidiary, include Human Resources, Supply Chain/Purchasing, Information Technology (IT), Technical Operations and Finances/Controlling. | Miscellaneous Commercial Services | General Counsel | |
Astellas Pharma SAS
Astellas Pharma SAS Medical DistributorsDistribution Services Astellas Pharma SAS wholesales pharmaceutical products. The company was founded in 2005 and is headquartered in Levallois-Perret, France. | Medical Distributors | Sales & Marketing | |
ICI Mutual Insurance Co.
ICI Mutual Insurance Co. Multi-Line InsuranceFinance ICI Mutual Insurance Co. provides risk management studies and practical advice to help insureds improve the risk profiles of their organizations. The private company is based in Washington and has subsidiaries in the United States. The American company also publish an annual newsletter called Claims Trends that provides an overview of the fund industry claims environment, including recent litigation developments, court decisions, and recent claims data. | Multi-Line Insurance | Director/Board Member | |
COLUMBIA SELIGMAN PREMIUM TECHNOLOGY GROWTH FUND | Investment Trusts/Mutual Funds | Director/Board Member | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
BLACK DIAMOND THERAPEUTICS, INC. | Biotechnology | Chief Operating Officer | |
Renovacor Holdings, Inc.
Renovacor Holdings, Inc. BiotechnologyHealth Technology Renovacor, Inc. operates as a preclinical stage biopharmaceutical company focused on developing transformative gene therapy based treatments for cardiovascular disease. The company is headquartered in Philadelphia, PA. | Biotechnology | Chairman | |
Asylia Therapeutics, Inc.
Asylia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Asylia Therapeutics, Inc. is a private biotechnology company founded in 2019 by Richard Jones, Robert Z. Orlowski, and Ronald A. DePinho. The company is based in Houston, TX. Asylia Therapeutics is focused on developing novel immune modulating therapies for cancer and autoimmune diseases. The company's drug pipeline is capable of modulating antigen presentation to the immune system, which has produced anti-tumor responses across multiple cancer models. The company is supported by a $3 million grant from the Cancer Prevention & Research Institute of Texas. The CEO is Karthik Radhakrishnan. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Basking Biosciences, Inc.
Basking Biosciences, Inc. BiotechnologyHealth Technology Basking Biosciences, Inc. is a clinical-stage company that aims to solve the biggest need in ischemic stroke therapy. The company is based in Columbus, OH. The company is developing a first-in-class RNA aptamer targeting von Willebrand factor (vWF), an important structural component of blood clots and driver of the clotting process. Basking is also developing a complementary rapid-acting reversal oligonucleotide capable of quickly neutralizing the pharmacological activity of the RNA aptamer. The company has successfully completed a phase 1 single-ascending dose safety study and is initiating a phase 2 clinical proof-of-concept study in patients suffering from an acute ischemic stroke. The ultimate goal is to extend the therapeutic window for thrombolysis compared to currently approved therapies. Basking Biosciences was founded in 2019 by Shahid Nimjee, Bruce A. Sullenger, and Richard J. Shea has been the CEO of the company since 2019. | Biotechnology | Chairman | |
RENOVACOR, INC. | Biotechnology | Director/Board Member |
Statistieken
Internationaal
Verenigde Staten | 41 |
Duitsland | 6 |
Frankrijk | 5 |
Zwitserland | 2 |
Sectoraal
Health Technology | 24 |
Consumer Services | 12 |
Commercial Services | 5 |
Health Services | 5 |
Miscellaneous | 4 |
Operationeel
Director/Board Member | 114 |
Corporate Officer/Principal | 77 |
Chairman | 21 |
Chief Tech/Sci/R&D Officer | 20 |
Independent Dir/Board Member | 19 |
Sterkste connecties
Insiders | |
---|---|
Friedrich von Bohlen und Halbach | 36 |
Michael Lytton | 24 |
Bernd Seizinger | 23 |
Alison Taunton-Rigby | 23 |
Peter Preuss | 19 |
Martine George | 18 |
Thomas E. Needham | 17 |
Mirko Scherer | 12 |
Lesley A. Stolz | 12 |
Jim Frates | 11 |
Jeno Gyuris | 11 |
Hemanshu Shah | 10 |
Torsten Hombeck | 10 |
Brent Hatzis-Schoch | 10 |
Thomas J. McKearn | 10 |
- Beurs
- Insiders
- Sebastian A. Meier-Ewert
- Bedrijfsconnecties